The American Cancer Society has updated its guidelines for prostate cancer screening, recommending that all men undergo routine testing for the disease. The new guidelines, released on Thursday, suggest that men at average risk should receive a prostate-specific antigen (PSA) test every two years from the age of 50 to 69. However, men considered to be at high risk due to their race or family history are advised to start testing earlier, at the age of 45. Specifically, Black men are recommended to undergo yearly testing starting at 45, as they have a higher incidence of prostate cancer. Non-Black men with a family history of prostate cancer are also advised to start testing at 45, with yearly screenings if they have a close relative diagnosed with the disease before the age of 65 or multiple relatives with a history of prostate cancer. In contrast, non-Black men with a single close relative diagnosed with prostate cancer at 65 or older should start testing at 45, but only receive screenings every two years. The updated guidelines aim to improve early detection and treatment of prostate cancer, potentially leading to better health outcomes for men. The American Cancer Society emphasizes the importance of discussing individual risk factors with a healthcare provider to determine the most suitable screening schedule. By taking proactive steps towards prostate cancer screening, men can increase their chances of early detection and effective treatment, ultimately improving their quality of life and reducing the risk of complications associated with the disease. The updated guidelines reflect the latest research and evidence on prostate cancer screening, and are intended to provide a more personalized approach to cancer prevention and treatment.